India begins its first human AIDS trial
India begins its first ever human clinical trial of an investigational vaccine candidate designed to treat HIV/AIDS, which now has a worldwide infection rate of 14,000 every day.
Archives for February 8, 2005
Biacore launches protein analysis system
Biacore International has launched the Biacore T100, a system that analyses the protein interactions that occur in disease pathways, selection of drug candidates and decisions on the safety of a protein therapeutic.
Alkermes to file first 'homegrown' product
US drug delivery company Alkermes has entered a new stage in its development as it gears up to file for marketing approval of its own product, rather than applying its technologies to drugs sold by customers.
First 900 MHz NMR magnet installation achieved
Bruker Biospin has announced the successful delivery and installation of its 900MHz NMR magnet, delivering the highest field strength actively shielded NMR magnet available today.
EiRx and Merck sign agreement
EiRx Therapeutics has entered into an agreement with Merck to carry out research using its cancer cell assays to use its technology for identifying drug targets.
2Q profits plunge at Cardinal Health
Pharmaceutical distribution and technology company Cardinal Health reported a slide in profits in the second quarter of the year, as an internal investigation into the company's accounting practices claimed additional executive casualties.
Terrorist fears drive bomb detector sales in pharma
A UK company is finding that the pharmaceutical industry is a lucrative new market for its under vehicle bomb detector, now that terrorist attacks are no longer confined to political and military targets.
Substance protects resilient Staph bacteria
Researchers have identified a promising new drug target in their fight against resilient Staphylococcus bacteria that can be transmitted to patients in hospitals via contaminated medical implants.
Lilly takes bar coding to unit dose level for insulin
In the US, drugmaker Eli Lilly has extended its bar coding to include individual vials of its insulin products, going beyond the requirements of recent labelling legislation aimed at cutting medication errors.